This study is looking at how CO2 laser treatment affects the vagina in women with Genitourinary Syndrome of Menopause (GSM). GSM is a condition caused by lower estrogen levels after menopause, leading to symptoms like vaginal dryness and painful intercourse. The CO2 laser is being explored as a non-hormonal treatment option for these symptoms. Researchers will use a special device called Optical Coherence Tomography (OCT) to measure changes in vaginal tissue, specifically vaginal epithelial thickness and blood vessel density. They want to see if the CO2 laser helps improve these measurements. You can join if you are a woman aged 18 or older, have GSM, and are willing to use vaginal laser therapy without other GSM treatments during the study. The study plans to enroll 50 participants, but its current recruitment status is unclear.

Study design

This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 50 women.

What's involved

Measurements will be taken once a month for the first three months, then every three months for one year. This involves using an OCT device in the vaginal canal.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for one year after the initial three months of monthly measurements.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.